Data / Form D filings / Nia Therapeutics, Inc.
Nia Therapeutics, Inc.: Form D filings
Nia Therapeutics, Inc., a health care company in Allston, MA, filed 13 Form D notices with the SEC between 2018 and 2026. The latest, on June 3, 2026, reports $23.6 million sold of a $26.5 million offering to 37 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 119 BRAINTREE ST. UNIT 703, Allston, MA, 02134
- Phone
- (267) 560-7402
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1758725
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Amendment | $26,499,997 | $23,573,844 | $2,926,153 | 37 | Dec 22, 2021 | sec.gov |
| Mar 6, 2026 | Amendment | $22,499,994 | $18,843,973 | $3,656,021 | 33 | Dec 22, 2021 | sec.gov |
| Jul 17, 2025 | Amendment | $18,500,000 | $15,637,194 | $2,862,806 | 28 | Dec 22, 2021 | sec.gov |
| Nov 25, 2024 | Amendment | $14,500,000 | $10,405,542 | $4,094,458 | 25 | Dec 22, 2021 | sec.gov |
| Feb 20, 2024 | Amendment | $9,500,000 | $8,543,906 | $956,094 | 24 | Dec 22, 2021 | sec.gov |
| Feb 20, 2024 | Amendment | $1 | $0 | $1 | 0 | Yet to occur | sec.gov |
| Feb 14, 2024 | New notice | $9,500,000 | $8,543,906 | $956,094 | 24 | Dec 22, 2021 | sec.gov |
| Dec 19, 2023 | Amendment | $8,000,000 | $6,324,949 | $1,675,051 | 18 | Dec 22, 2021 | sec.gov |
| Dec 23, 2022 | Amendment | $8,000,000 | $6,224,956 | $1,775,044 | 17 | Dec 22, 2021 | sec.gov |
| Dec 30, 2021 | New notice | $8,000,000 | $2,000,002 | $5,999,998 | 4 | Dec 22, 2021 | sec.gov |
| Sep 4, 2020 | New notice | $2,000,000 | $1,500,000 | $500,000 | 3 | Jul 8, 2020 | sec.gov |
| Sep 12, 2019 | New notice | $2,000,000 | $200,000 | $1,800,000 | 1 | Sep 4, 2019 | sec.gov |
| Nov 13, 2018 | New notice | $2,000,000 | $850,000 | $1,150,000 | 3 | Oct 31, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Rizzuto | Executive Officer, Director | |
| Daniel Utin | Executive Officer | |
| Larry Greenberg | Director | |
| Jonathan Wachter | Director | |
| Milton Morris | Director | |
| Michael Kahana | Executive Officer, Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Nia Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.